[Federal Register: July 27, 2005 (Volume 70, Number 143)]
[Notices]               
[Page 43455]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27jy05-120]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By notice dated February 23, 2005, and published in the Federal 
Register on March 4, 2005 (70 FR 10680), Lin Zhi International Inc., 
687 North Pastoria Avenue, Sunnyvale, California 94085 made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of the basic class of controlled 
substances listed in Schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for use in analysis and drug test standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Lin Zhi International Inc. to manufacture the listed basic class of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Lin Zhi International Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substances listed.

    Dated: July 19, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-14828 Filed 7-26-05; 8:45 am]

BILLING CODE 4410-09-P